The Wild West of Checkpoint Inhibitor Development
N Engl J Med
.
2022 Apr 7;386(14):1297-1301.
doi: 10.1056/NEJMp2116863.
Epub 2021 Dec 15.
Authors
Julia A Beaver
1
,
Richard Pazdur
1
Affiliation
1
From the Oncology Center of Excellence, Food and Drug Administration, Silver Spring, MD.
PMID:
34910860
DOI:
10.1056/NEJMp2116863
No abstract available
MeSH terms
Drug Development*
Humans
Immune Checkpoint Inhibitors*
Substances
Immune Checkpoint Inhibitors